PKN2 and colorectal carcinoma: Our current study indicates that PKN2 knockdown significantly increases cell viability and cell survival, induces cell cycle arrest at G0/G1 phase and cell apoptosis, whereas at least partly reverses the SNTB1 knockdown medicated cell proliferation suppression, cell cycle arrest and cell apoptosis in CRC cells.